Abstract
A spectrophotometric method for the selective determination of antimony (III) and (V) in antileishmanial drugs is described. The procedure is based on the reaction of Sb(III) with bromopyrogallol red (BPR) in neutral solution. As a consequence of the Sb-BPR complex formed, the absorbance of BPR, at 560 nm, decreases proportionally to the amount of Sb(III) in the analyte solution. The calculated apparent molar absorptivity and determination limits are 3.67 × 104 L · cm–1 · mol–1 and 1.65 × 10–6 mol/L, respectively. Sb(V) is determined after reduction to Sb(III) by iodide. The Sb(V) content determined in ten samples of Glucantime varied from 75.40 ± 0.97 to 94.47 ± 1.0 mg/mL. Sb(III) was detected in all samples analyzed, and mean values ranged from 5.19 ± 0.16 to 10.52 ± 0.15 mg/mL. The method is suitable for the routine quality control of pharmaceutical formulations.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 26 July 1996 / Revised: 17 October 1996 / Accepted: 11 December 1996
Rights and permissions
About this article
Cite this article
Rath, S., Jardim, W. & Dórea, J. A simple spectrophotometric procedure for the determination of antimony (III) and (V) in antileishmanial drugs. Fresenius J Anal Chem 358, 548–550 (1997). https://doi.org/10.1007/s002160050466
Issue Date:
DOI: https://doi.org/10.1007/s002160050466